November 3, 2023
National Cancer Institute (NCI)
The purpose of this notice of participation is to inform the extramural community that NCI is participating in RFA-HG-23-002, Broadening Opportunities for Computational Genomics and Data Science Education (UE5 – Clinical Trial Not Allowed).
The following changes in RFA-HG-23-002 reflect NCI's participation (in bold italics):
Components of Participating Organizations
National Human Genome Research Institute (NHGRI) (https://www.genome.gov/)
National Cancer Institute (NCI)
Assistance Listing Number(s)
93.172; 93.398
Section I. Funding Opportunity Description
The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.
The NIH Research Education Program (UE5) supports research educational activities that complement other formal training programs in the mission areas of the NIH Institutes and Centers.
The overarching goal of this UE5 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in computational genomics and data science research.
This NOFO will support educational activities with a primary focus on:
Specifically, this NOFO will support the development of undergraduate and masters degree-level classroom content, and hands-on as well as online exercises related to computational genomics, data science, cloud computing, or a combination of these topics, tailored towards students attending institutions with a mission to serve historically underrepresented populations in biomedical research as described below in Section III.
The National Cancer Institute encourages applications focused on educational activities that are related to computational cancer genomics, cancer data science, cloud computing for cancer focused activities, or a combination of these topics, tailored towards students attending institutions with a mission to serve historically underrepresented populations in biomedical research as described below in Section III.
Scientific/Research Contact(s)
Shurjo K. Sen, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-827-7028
Email: [email protected]
Nastaran Zahir, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6333
Email: [email protected]
Peer Review Contact(s)
Rudy Pozzatti, Ph.D.
National Human Genome Research Institute (NHGRI)
Telephone: 301-402-8739
Email: [email protected]
Financial/Grants Management Contact(s)
Donna Morris
National Human Genome Research Institute (NHGRI)
Telephone: 301-827-2745
Email: [email protected] (mailto:[email protected])
Crystal Wolfrey
National Cancer Institute (NCI)
Telephone: 240-276-6277
Email: [email protected]
All other aspects of RFA-HG-23-002 remain unchanged.
Nastaran Zahir, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6333
Email: [email protected]